key articles
Association between lower urinary tract symptoms and serum sex hormones in men
Friday, 1 August 2008 - Despite the well-known association between lower urinary tract symptoms (LUTS) and male sexual dysfunction, few data are available that describe the relationship between LUTS and sex hormones. Miwa et al....
Progression of benign prostatic hyperplasia
Wednesday, 9 July 2008 - Emberton et al. (2008) systematically reviewed the placebo arms of randomized trials of medical therapy for benign prostatic hyperplasia (BPH) and thus estimate rates of progression.
The authors searched...
Functional outcome following photoselective vaporisation of the prostate: urodynamic findings of 12 months follow-up
Monday, 23 June 2008 - Hamann et al. (2008) determined the impact of potassium-titanyl-phosphate (KTP) laser therapy of the prostate on urodynamic results, voiding function, quality of life, and sexual function.
Forty-five...
Transurethral ethanol ablation of prostate: an effective minimally invasive option
Wednesday, 18 June 2008 - Magno et al. (2008) evaluated the efficacy and safety of transurethral ethanol ablation of the prostate (TEAP) for patients with symptomatic benign prostatic hyperplasia (BPH) and high-risk...
High-power potassium-titanyl-phosphate laser photoselective vaporization prostatectomy
Tuesday, 17 June 2008 - Potassium-titanyl-phosphate (KTP) laser photoselective vaporization prostatectomy (PVP) is a relatively new technology for the management of lower urinary-tract symptoms (LUTS) secondary to benign...
Guide to risk factors and options for management of benign prostatic hyperplasia
Tuesday, 17 June 2008 - In a review, Emberton et al. (2008) discussed current knowledge of the progressive nature of benign prostatic hyperplasia (BPH) and how the risk of BPH progression can be evaluated toguide therapeutic...
GreenLight laser vaporization of the prostate: single-center experience and long-term results
Monday, 16 June 2008 - Long-term data of photoselective vaporization of the prostate (PVP) for treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) is scanty. Ruszat et al. (2008)...
Phase 2 study of cetrorelix for symptomatic benign prostatic hyperplasia
Monday, 2 June 2008 - Pilot studies with daily dosing suggested the use of the luteinizing hormone-releasing hormone antagonist cetrorelix (CET) for the treatment of symptoms from benign prostatic hyperplasia (BPH). Debruyne et...
Prostate Holmium Laser Enucleation: Safety, Efficacy, and Learning Experience in China
Monday, 26 May 2008 - Holmium laser enucleation of the prostate (HoLEP) is a well established procedure for the treatment of benign prostatic hyperplasia. Du et al. (2008) reported their experience of the learning curve,...











